Diabetes Market Size, Share & Trends Analysis | United States | 2019-2025 | MedSuite | Includes: Insulin Pumps, Insulin Syringes, Continuous Glucose Monitoring, and 6 more
- Year: 2019
- Scope: 2015-2025
- Region: United States
- Pages: 287
- Type: MedSuite
The U.S. diabetes monitoring, treatment, and drug delivery market, also referred to as the diabetes care market, includes blood glucose meters, blood glucose test strips, lancets, continuous glucose monitoring (CGM), flash glucose monitoring (FGM), insulin, insulin pens, insulin syringes, and insulin pumps.
Previously, the U.S. diabetes monitoring, treatment, and drug-delivery market was valued at $15.7 billion. However, an increase is projected over the forecast period to reach approximately $16.4 billion by 2025 at a CAGR of 0.6%. The growth over the forecast period for this market can be attributed to demographic factors, increasing obesity rates, and the conversion to safety products.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2025, and Historical Data to 2015
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
U.S. DIABETES CARE MARKET INSIGHTS
The diabetes care market decreased in value in 2018, but growth is expected to return to positive levels over the forecast period. The primary driver of growth will be the expanding diabetic population in the U.S. and the increasing number of patients that require various diabetes care devices to manage their disease on a daily basis. Limitations to market growth include pricing pressure, due to Centers for Medicare & Medicaid Services (CMS) reimbursement changes, and a lack of reimbursement for new devices, such as CGM and FGM, for the non-insulin-dependent diabetic population.
U.S. DIABETES CARE MARKET SHARE INSIGHTS
Novo Nordisk, Eli Lilly, and Sanofi controlled the U.S. diabetes care market. Novo Nordisk held the leading position in the ultra-long-acting insulin rapid-acting insulin markets and the second-leading position in the long-acting insulin, premixed insulin, and human insulin markets.
RESEARCH REGIONAL COVERAGE
Throughout this report, iData Research has extensively covered the U.S. market in great detail. The regions covered are:
- North America (United States)
All Companies Analyzed in this Study
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.